Survey and Biospecimen Shared Resource
调查和生物样本共享资源
基本信息
- 批准号:10682619
- 负责人:
- 金额:$ 13.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1998
- 资助国家:美国
- 起止时间:1998-09-01 至 2025-08-31
- 项目状态:未结题
- 来源:
- 关键词:AchievementAdverse eventBioinformaticsBiologicalBiological AssayBiological MarkersBiostatistics Shared ResourceBloodCancer CenterCancer Center Support GrantCancer ControlCase/Control StudiesClinicalClinical InvestigatorClinics and HospitalsCollectionCommunitiesComputer AssistedConsultationsDNADataData CollectionData ScienceDietDoctor of PhilosophyEffectivenessEnsureEnvironmental ExposureEpidemiologistEpidemiologyFacultyFamilyFecesGeneticGenetic MarkersGenotypeGoalsHealthImmunohistochemistryIndividualIndustry StandardInterviewerInvestmentsJournalsLaboratoriesMalignant NeoplasmsManuscriptsMedical RecordsMentorshipMetagenomicsMethodsMissionMolecularMolecular EpidemiologyMonitorNCI Center for Cancer ResearchNatureOral cavityOutcome StudyParticipantPatient RecruitmentsPeer ReviewPharmaceutical PreparationsPopulationPopulation ResearchPopulation SciencesPopulation StudyPostdoctoral FellowPreventionProceduresProspective cohortProspective, cohort studyProtocols documentationPublicationsPublishingQuality ControlQuality of lifeRNARecording of previous eventsReproducibilityResearchResearch DesignResearch PersonnelResearch Project GrantsResource SharingResourcesRetrievalSalivaSamplingServicesStainsStudentsSurveysSymptomsSystemTelephone InterviewsTennesseeTimeTissuesTrainingUnited StatesUniversitiesUrineVariantWorkanticancer researchbiobankcancer epidemiologycostcost efficientdeep sequencingdesigndoctoral studentepidemiology studyexperiencegenome sciencesimprovedmedical schoolsmembermetatranscriptomicsmicrobiome researchmolecular markernano-stringnew technologynext generationparticipant enrollmentpopulation basedprogramsrandomized trialrecruitresearch studyresponsible research conductsample collectionservice utilizationtranslational study
项目摘要
CORE 011 – SURVEY AND BIOSPECIMEN SHARED RESOUCE
PROJECT SUMMARY/ABSTRACT
The mission of the Survey and Biospecimen Shared Resource (SBSR) is to provide high-quality survey and
laboratory services to support the Vanderbilt-Ingram Cancer Center (VICC) research community, inclusive of our
VICC members and partners at Meharry Medical College, Tennessee State University, and other NCI Cancer
Centers. This mission is fulfilled through two distinct but complementary functions: survey research services and
laboratory services. The survey services include consultation for study design or implementation, survey
programming, participant enrollment, computer-assisted telephone interviewing, medical record review and
study mailings. The laboratory services include consultation for study design, biospecimen collection,
processing, storage and retrieval, DNA/RNA extraction, genotyping, and biomarker assays. The SBSR also
manages biorepositories for multiple studies including from three large prospective cohort studies and several
large case-control studies. The scientific co-Directors of the SBSR have directed studies involving data and
biologic sample collection from more than 200,000 study participants in the United States and abroad. Thus, the
SBSR provides VICC members with access to significant expertise and capabilities in large-scale population-
based research; avoids the start-up costs associated with hiring and training staff for data collection and sample
processing; shares experienced research staff to reduce study costs; implements rigorous quality control
protocols; and enables high quality specimen and data collection and processing. The major scientific
achievement of the SBSR is reflected in the service utilization and publications. The SBSR supports multiple
studies that are recruiting participants, collecting survey data and/or biospecimens, or performing biological
assays on collected samples. Twenty-six VICC members have benefited from the services of the resource to
improve study design and research quality. VICC members with peer-reviewed support account for 91% and
98% of total service usage for the laboratory services and survey services, respectively. This shared resource
has supported the publication of over 200 cancer-related manuscripts published since 2015 including in journals
such as JAMA, Nature, Nature Genetics, JNCI and Cancer Research. Through the implementation and sharing
of best practices, the SBSR staff demonstrates to users the effectiveness of a rigorous approach to the conduct
of population-based research, which enables individual investigators, students, fellows and staff to better
incorporate these practices into their research programs. Thus, the SBSR services are critical for the research
conducted by VICC members across multiple VICC research programs.
核心 011 – 调查和生物样本共享资源
项目概要/摘要
调查和生物样本共享资源 (SBSR) 的使命是提供高质量的调查和
实验室服务支持范德比尔特-英格拉姆癌症中心 (VICC) 研究社区,包括我们的
VICC 成员以及梅哈里医学院、田纳西州立大学和其他 NCI 癌症中心的合作伙伴
这一使命是通过两个不同但互补的职能来实现的:调查研究服务和
实验室服务包括研究设计或实施的咨询、调查。
编程、参与者登记、计算机辅助电话访谈、医疗记录审查和
研究邮件。实验室服务包括研究设计咨询、生物样本收集、
SBSR 还包括处理、存储和检索、DNA/RNA 提取、基因分型和生物标志物测定。
管理多项研究的生物样本库,包括三项大型前瞻性队列研究和多项研究
SBSR 的科学联合主任指导了涉及数据和研究的大型病例对照研究。
从美国和国外超过 200,000 名研究参与者收集了生物样本。
SBSR 为 VICC 成员提供了在大规模人群中获得重要专业知识和能力的机会
基于研究;避免与雇用和培训数据收集和样本人员相关的启动成本
处理;共享经验丰富的研究人员以降低研究成本;实施严格的质量控制;
协议;并实现高质量的样本和数据收集和处理。
SBSR 的成就体现在服务利用和出版物上。
招募、收集调查数据和/或生物样本或进行生物学研究
二十六名 VICC 成员已从该资源的服务中受益。
获得同行评审支持的 VICC 成员占 91%,并且
实验室服务和调查服务分别占总服务使用量的 98%。
自 2015 年以来,已支持发表 200 多篇与癌症相关的手稿,其中包括期刊
例如 JAMA、Nature、Nature Genetics、JNCI 和 Cancer Research 通过实施和共享。
SBSR 工作人员向用户展示了严格的最佳实践方法的有效性
以人群为基础的研究,使个人研究人员、学生、研究员和工作人员能够更好地
因此,SBSR 服务对于研究至关重要。
由 VICC 成员在多个 VICC 研究项目中进行。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
QIUYIN CAI其他文献
QIUYIN CAI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('QIUYIN CAI', 18)}}的其他基金
Menthol cigarette smoking-related blood metabolites and lung cancer risk
薄荷醇香烟与吸烟相关的血液代谢物和肺癌风险
- 批准号:
10653537 - 财政年份:2023
- 资助金额:
$ 13.9万 - 项目类别:
Searching the blood metabolome to identify risk biomarkers for biliary tract cancer
搜索血液代谢组以确定胆道癌的风险生物标志物
- 批准号:
10614032 - 财政年份:2022
- 资助金额:
$ 13.9万 - 项目类别:
Searching the blood metabolome to identify risk biomarkers for biliary tract cancer
搜索血液代谢组以确定胆道癌的风险生物标志物
- 批准号:
10453004 - 财政年份:2022
- 资助金额:
$ 13.9万 - 项目类别:
Individual and social contextual factors in relation to DNA methylation, biological aging, and lung cancer risk
与 DNA 甲基化、生物衰老和肺癌风险相关的个人和社会背景因素
- 批准号:
10474423 - 财政年份:2021
- 资助金额:
$ 13.9万 - 项目类别:
Identification of Genes and DNA Methylation Markers for Lung Cancer Risk by Integrating Multi-omics Data
通过整合多组学数据鉴定肺癌风险基因和 DNA 甲基化标记
- 批准号:
10331874 - 财政年份:2021
- 资助金额:
$ 13.9万 - 项目类别:
Identification of Genes and DNA Methylation Markers for Lung Cancer Risk by Integrating Multi-omics Data
通过整合多组学数据鉴定肺癌风险基因和 DNA 甲基化标记
- 批准号:
10531620 - 财政年份:2021
- 资助金额:
$ 13.9万 - 项目类别:
Individual and social contextual factors in relation to DNA methylation, biological aging, and lung cancer risk
与 DNA 甲基化、生物衰老和肺癌风险相关的个人和社会背景因素
- 批准号:
10306010 - 财政年份:2021
- 资助金额:
$ 13.9万 - 项目类别:
Individual and social contextual factors in relation to DNA methylation, biological aging, and lung cancer risk
与 DNA 甲基化、生物衰老和肺癌风险相关的个人和社会背景因素
- 批准号:
10600037 - 财政年份:2021
- 资助金额:
$ 13.9万 - 项目类别:
相似海外基金
A translational bioinformatics approach to elucidate and mitigate polypharmacy induced adverse drug reactions
阐明和减轻复方用药引起的药物不良反应的转化生物信息学方法
- 批准号:
10507532 - 财政年份:2022
- 资助金额:
$ 13.9万 - 项目类别:
A translational bioinformatics approach to elucidate and mitigate polypharmacy induced adverse drug reactions
阐明和减轻复方用药引起的药物不良反应的转化生物信息学方法
- 批准号:
10664024 - 财政年份:2022
- 资助金额:
$ 13.9万 - 项目类别:
Washington Obstetric-Fetal Pharmacology Research Unit
华盛顿产胎儿药理学研究单位
- 批准号:
7695403 - 财政年份:2004
- 资助金额:
$ 13.9万 - 项目类别: